{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T18:51:27Z","timestamp":1773168687979,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,5,31]],"date-time":"2021-05-31T00:00:00Z","timestamp":1622419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,31]],"date-time":"2021-05-31T00:00:00Z","timestamp":1622419200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Head and Neck Pathol"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s12105-021-01338-0","type":"journal-article","created":{"date-parts":[[2021,5,31]],"date-time":"2021-05-31T05:02:52Z","timestamp":1622437372000},"page":"1246-1252","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["INI1-Deficient Thyroid Carcinoma is an Aggressive Disease with Epithelioid and Rhabdoid Phenotype. A Case Report, Survey of INI1 Expression in Thyroid Lesions and Literature Review"],"prefix":"10.1007","volume":"15","author":[{"given":"Zhonghua","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mukund","family":"Seshadri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vishal","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonios","family":"Papanicolau-Sengos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0922-4097","authenticated-orcid":false,"given":"Mihai","family":"Merzianu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,31]]},"reference":[{"key":"1338_CR1","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.5858\/2005-129-e55-RTOTTG","volume":"129","author":"ML Lai","year":"2005","unstructured":"Lai ML, Faa G, Serra S, Senes G, Daniele GM, Boi F, et al. Rhabdoid tumor of the thyroid gland: a variant of anaplastic carcinoma. Arch Pathol Lab Med. 2005;129:e55\u20137.","journal-title":"Arch Pathol Lab Med"},{"key":"1338_CR2","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.anl.2016.03.006","volume":"43","author":"YT Lu","year":"2016","unstructured":"Lu YT, Huang HI, Yang AH, Tai SK. Thyroid carcinoma with rhabdoid phenotype: case report with review of the literature. Auris Nasus Larynx. 2016;43:706\u20139.","journal-title":"Auris Nasus Larynx"},{"key":"1338_CR3","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1089\/thy.2020.0086","volume":"30","author":"B Xu","year":"2020","unstructured":"Xu B, Fuchs T, Dogan S, Landa I, Katabi N, Fagin JA, et al. Dissecting anaplastic thyroid carcinoma: a comprehensive clinical, histologic, immunophenotypic, and molecular study of 360 cases. Thyroid. 2020;30:1505\u201317.","journal-title":"Thyroid"},{"key":"1338_CR4","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1097\/PAS.0000000000000797","volume":"41","author":"A Agaimy","year":"2017","unstructured":"Agaimy A, Hartmann A, Antonescu CR, Chiosea SI, El-Mofty SK, Geddert H, et al. SMARCB1 (INI1)-deficient sinonasal carcinoma: a series of 39 cases expanding the morphologic and clinicopathologic spectrum of a recently described entity. Am J Surg Pathol. 2017;41:458\u201371.","journal-title":"Am J Surg Pathol"},{"key":"1338_CR5","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1111\/cas.13173","volume":"108","author":"K Kohashi","year":"2017","unstructured":"Kohashi K, Oda Y. Oncogenic roles of SMARCB1\/INI1 and its deficient tumors. Cancer Sci. 2017;108:547\u201352.","journal-title":"Cancer Sci"},{"key":"1338_CR6","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1053\/j.semdp.2016.08.003","volume":"33","author":"CE Fuller","year":"2016","unstructured":"Fuller CE. All things rhabdoid and SMARC: an enigmatic exploration with Dr. Louis P. Dehner. Semin Diagn Pathol. 2016;33:427\u201340.","journal-title":"Semin Diagn Pathol"},{"key":"1338_CR7","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1097\/PAP.0000000000000038","volume":"21","author":"A Agaimy","year":"2014","unstructured":"Agaimy A. The expanding family of SMARCB1(INI1)-deficient neoplasia: implications of phenotypic, biological, and molecular heterogeneity. Adv Anat Pathol. 2014;21:394\u2013410.","journal-title":"Adv Anat Pathol"},{"key":"1338_CR8","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/modpathol.2014.100","volume":"28","author":"A Agaimy","year":"2015","unstructured":"Agaimy A, Haller F, Frohnauer J, Schaefer IM, Strobel P, Hartmann A, et al. Pancreatic undifferentiated rhabdoid carcinoma: KRAS alterations and SMARCB1 expression status define two subtypes. Mod Pathol. 2015;28:248\u201360.","journal-title":"Mod Pathol"},{"key":"1338_CR9","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.humpath.2020.08.004","volume":"104","author":"S Dogan","year":"2020","unstructured":"Dogan S, Cotzia P, Ptashkin RN, Nanjangud GJ, Xu B, Momeni Boroujeni A, et al. Genetic basis of SMARCB1 protein loss in 22 sinonasal carcinomas. Hum Pathol. 2020;104:105\u201316.","journal-title":"Hum Pathol"},{"key":"1338_CR10","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1111\/j.1440-1827.2010.02575.x","volume":"60","author":"A D'Antonio","year":"2010","unstructured":"D\u2019Antonio A, Orabona P, Caleo A, Addesso M, Liguori G, Boscaino A. Primary rhabdoid tumor of thyroid gland. Description of a rare entity with molecular study. Pathol Int. 2010;60:644\u20136.","journal-title":"Pathol Int"},{"key":"1338_CR11","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.prp.2005.10.004","volume":"202","author":"K Sato","year":"2006","unstructured":"Sato K, Waseda R, Tatsuzawa Y, Soma R, Ueda Y, Katsuda S. Papillary thyroid carcinoma with anaplastic transformation showing a rhabdoid phenotype solely in the cervical lymph node metastasis. Pathol Res Pract. 2006;202:55\u20139.","journal-title":"Pathol Res Pract"},{"key":"1338_CR12","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s004280050410","volume":"435","author":"R Chetty","year":"1999","unstructured":"Chetty R, Govender D. Follicular thyroid carcinoma with rhabdoid phenotype. Virchows Arch. 1999;435:133\u20136.","journal-title":"Virchows Arch"},{"key":"1338_CR13","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1507\/endocrj.EJ15-0705","volume":"63","author":"M Hirokawa","year":"2016","unstructured":"Hirokawa M, Sugitani I, Kakudo K, Sakamoto A, Higashiyama T, Sugino K, et al. Histopathological analysis of anaplastic thyroid carcinoma cases with long-term survival: a report from the Anaplastic Thyroid Carcinoma Research Consortium of Japan. Endocr J. 2016;63:441\u20137.","journal-title":"Endocr J"},{"key":"1338_CR14","doi-asserted-by":"publisher","first-page":"152830","DOI":"10.1016\/j.prp.2020.152830","volume":"216","author":"S Agarwal","year":"2020","unstructured":"Agarwal S, Kakkar A, Damle NA, Kumar C, Sarangi J, Subudhi K, et al. SMARCB1 (INI1)-deficient thyroid carcinoma: a novel entity expanding the spectrum of tumors with INI1 loss. Pathol Res Pract. 2020;216:152830.","journal-title":"Pathol Res Pract"},{"key":"1338_CR15","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3390\/diagnostics10050280","volume":"10","author":"KC Ho","year":"2020","unstructured":"Ho KC, Lee JJ, Lin CH, Leung CH, Cheng SP. Loss of integrase interactor 1 (INI1) expression in a subset of differentiated thyroid cancer. Diagnostics. 2020;10:280.","journal-title":"Diagnostics"},{"key":"1338_CR16","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1172\/JCI85271","volume":"126","author":"I Landa","year":"2016","unstructured":"Landa I, Ibrahimpasic T, Boucai L, Sinha R, Knauf JA, Shah RH, et al. Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers. J Clin Investig. 2016;126:1052\u201366.","journal-title":"J Clin Investig"},{"key":"1338_CR17","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.jasc.2020.07.134","volume":"9","author":"BE Kezlarian","year":"2020","unstructured":"Kezlarian BE, Lin O, Dogan S. SMARCB1-deficient carcinomas of the head and neck region: a cytopathologic characterization. J Am Soc Cytopathol. 2020;9:494\u2013501.","journal-title":"J Am Soc Cytopathol"},{"key":"1338_CR18","first-page":"474","volume":"98","author":"P Cotzia","year":"2018","unstructured":"Cotzia P, Ptashkin R, Gounder M, Pfister D, Berger M, Ladanyi M, Ghossein R, Antonescu CR, Dogan S. Genetic and histologic spectrum of SMARCB1-deficient carcinomas of the head and neck including sinonasal tract, thyroid and skin. Mod Pathol. 2018;98:474\u20135.","journal-title":"Mod Pathol"},{"key":"1338_CR19","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/path.2103","volume":"211","author":"F Bourdeaut","year":"2007","unstructured":"Bourdeaut F, Fr\u00e9neaux P, Thuille B, Lellouch-Tubiana A, Nicolas A, Couturier J, et al. hSNF5\/INI1-deficient tumours and rhabdoid tumours are convergent but not fully overlapping entities. J Pathol. 2007;211:323\u201330.","journal-title":"J Pathol"},{"key":"1338_CR20","doi-asserted-by":"publisher","first-page":"5970","DOI":"10.1158\/1078-0432.CCR-17-1183","volume":"23","author":"T Ibrahimpasic","year":"2017","unstructured":"Ibrahimpasic T, Xu B, Landa I, Dogan S, Middha S, Seshan V, et al. Genomic alterations in fatal forms of non-anaplastic thyroid cancer: identification of MED12 and RBM10 as novel thyroid cancer genes associated with tumor virulence. Clin Cancer Res. 2017;23:5970\u201380.","journal-title":"Clin Cancer Res"},{"key":"1338_CR21","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.jamcollsurg.2015.12.047","volume":"222","author":"SC Pitt","year":"2016","unstructured":"Pitt SC, Hernandez RA, Nehs MA, Gawande AA, Moore FD Jr, Ruan DT, Cho NL. Identification of novel oncogenic mutations in thyroid cancer. J Am Coll Surg. 2016;222:1036\u201343.","journal-title":"J Am Coll Surg"},{"key":"1338_CR22","doi-asserted-by":"publisher","first-page":"R415","DOI":"10.1530\/ERC-19-0093","volume":"26","author":"C Zafon","year":"2019","unstructured":"Zafon C, Gil J, P\u00e9rez-Gonz\u00e1lez B, Jord\u00e0 M. DNA methylation in thyroid cancer. Endocr Relat Cancer. 2019;26:R415\u201339.","journal-title":"Endocr Relat Cancer"},{"issue":"22","key":"1338_CR23","doi-asserted-by":"publisher","first-page":"3582","DOI":"10.1158\/1078-0432.CCR-15-1749","volume":"15","author":"XM Yu","year":"2016","unstructured":"Yu XM, Jaskula-Sztul R, Georgen MR, Aburjania Z, Somnay YR, Leverson G, et al. Notch1 signaling regulates the aggressiveness of differentiated thyroid cancer and inhibits SERPINE1 expression. Clin Cancer Res. 2016;15(22):3582\u201392.","journal-title":"Clin Cancer Res"},{"key":"1338_CR24","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13000-016-0500-8","volume":"11","author":"M Matsuo","year":"2016","unstructured":"Matsuo M, Tuneyoshi M, Mine M. Primary mucinous carcinoma with rhabdoid cells of the thyroid gland: a case report. Diagn Pathol. 2016;11:48.","journal-title":"Diagn Pathol"},{"key":"1338_CR25","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.humpath.2005.04.012","volume":"36","author":"T Kondo","year":"2005","unstructured":"Kondo T, Kato K, Nakazawa T, Miyata K, Murata S, Katoh R. Mucinous carcinoma (poorly differentiated carcinoma with extensive extracellular mucin deposition) of the thyroid: a case report with immunohistochemical studies. Hum Pathol. 2005;36:698\u2013701.","journal-title":"Hum Pathol"},{"key":"1338_CR26","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/S1470-2045(20)30451-4","volume":"21","author":"M Gounder","year":"2020","unstructured":"Gounder M, Schoffski P, Jones RL, Agulnik M, Cote GM, Villalobos VM, et al. Tazemetostat in advanced epithelioid sarcoma with loss of INI1\/SMARCB1: an international, open-label, phase 2 basket study. Lancet Oncol. 2020;21:1423\u201332.","journal-title":"Lancet Oncol"}],"container-title":["Head and Neck Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12105-021-01338-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12105-021-01338-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12105-021-01338-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T06:40:27Z","timestamp":1638340827000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12105-021-01338-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,31]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1338"],"URL":"https:\/\/doi.org\/10.1007\/s12105-021-01338-0","relation":{},"ISSN":["1936-0568"],"issn-type":[{"value":"1936-0568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,31]]},"assertion":[{"value":"17 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Roswell Park Comprehensive Cancer Center Institutional Review Board (I 281415\/2020).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed consent was obtained.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}